Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
March-2022 Volume 25 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
March-2022 Volume 25 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Cellular response of lung fibroblasts and epithelial cells to particulate matter10 treatment examined via comparative transcriptome analysis

  • Authors:
    • Kunhyang Park
    • Kwangho Kim
    • Tae Young Ryu
    • Jinkwon Lee
    • Moo-Seung Lee
    • Mi-Young Son
    • Seon-Jin Lee
    • Young-Jun Park
    • Hyun-Soo Cho
    • Dae-Soo Kim
  • View Affiliations / Copyright

    Affiliations: Environmental Diseases Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Republic of Korea
  • Article Number: 82
    |
    Published online on: January 13, 2022
       https://doi.org/10.3892/mmr.2022.12598
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Particulate matter (PM) can be categorized by particle size (PM10, PM2.5 and PM1.0), which is an important factor affecting the biological response. Exposure to PM in the air (dust, smoke, dirt and biological contaminants) is clearly associated with lung disease (lung cancer, pneumonia and asthma). Although PM primarily affects lung epithelial cells, the specific response of related cell types to PM remains to be elucidated. The present study performed Gene Ontology (GO) analysis programs (Clustering GO and Database for Annotation, Visualization and Integrated Discovery) on differentially expressed genes in lung epithelial cells (WI‑38 VA‑13) and fibroblasts (WI‑38) following treatment with PM10 and evaluated the cell‑specific biological responses related to cell proliferation, apoptosis, adhesion and extracellular matrix production. The results suggested that short‑ or long‑term exposure to PM may affect cell condition and may consequently be related to several human diseases, including lung cancer and cardiopulmonary disease.

Introduction

Particulate matter (PM), also called particle pollution, is the suspension of liquid or solid particles in the air and includes inorganic and organic particles such as smoke, dust, pollen, biological contaminants, heavy metals and dirt (1–3). PM can be classified by the diameter of the particles, including PM10, PM2.5 and PM1.0, and size is an important factor affecting the cellular response (3–5). Exposure to PM is linked to heart disease (cardiopulmonary disease, cardiac arrest and cardiovascular/hypertensive disease), lung disease (pneumonia, lung cancer, asthma and chronic obstructive lung disease) and neurodegeneration (1,6). The treatment of cells with PM is associated with both an inflammatory response and a pro-oxidative response (7). For example, PM (PM10 and PM2.5) treatments induce Akt activation via phosphorylation at Ser473 and Thr308 in human lung epithelial cells (BEAS-2B) (8). Additionally, coal and silica dust treatments induce alterations in DNA methylation patterns via changes in DNA methyltransferase (DNMT) 1, DNMT3α, DNMT3β, methyl CpG binding protein 2 and methyl-CpG binding domain protein 2 expression (9,10). In addition, the treatment of A549 cells with PM2.5 results in cytotoxicity and genotoxicity (3).

PM stimulates the immune system in the lungs and respiratory tract. Following inhalation, PM accumulates in air exchange regions of the lung, including the alveoli and stimulates defense mechanisms involving alveolar epithelial cells or macrophages (11). Lung tissue consists of various cell types, such as epithelium and fibroblasts, that maintain homeostasis and defense mechanisms in the lungs (12). Fibroblasts are responsible for maintaining the alveolar structure during repair and proliferation in injured regions (13). The lung epithelium provides an inert barrier for gas exchange and bulk airflow (14). Although PM exposure occurs in lung epithelial cells, the cell-specific responses of lung epithelial cells and fibroblasts to PM remain to be elucidated.

Thus, the present study performed an RNA-sequencing (RNA-seq) analysis on lung epithelial cells (WI-38 VA-13) and fibroblast cells (WI-38) following treatment with PM10 and used Gene Ontology (GO) analysis programs [Clustering GO (ClueGO) and Database for Annotation, Visualization and Integrated Discovery (DAVID)] to identify the cell-specific responses to PM.

Materials and methods

PM10 sampling and components

The fine dust ERM®-CZ100 (PM10) was purchased from Sigma-Aldrich (Merck KGaA). PM10 packaged in amber glass vials was used to prepare stock solutions in phosphate-buffered saline (PBS; 100 mg/ml) and experiments using the suspended PM10 composition were performed immediately. The PM10 used contained the following polyaromatic hydrocarbons (PAHs): i) Benzo(a)anthracene; ii) benzo(a)pyrene; iii) benzo(b)fluoranthene; iv) benzo(l)fluoranthene; v) benzo(k)fluoranthene; vi) dibenz(a,h)anthracene; vii) indeno(1,2,3-cd)pyrene; and viii) a combination of benzo(b)fluoranthene, benzo(k)fluoranthene and benzo(l)fluoranthene.

Cell culture and treatment

The normal human lung cell lines WI-38 and WI-38 VA-13 subclone 2RA (WI-38 VA-13) were purchased from the Korean Cell Line Bank (Korean Cell Line Research Foundation) and cultured in MEM (HyClone; Cytiva) and RPMI-1640 medium (Welgene, Inc.), respectively, supplemented with 10% fetal bovine serum (FBS; Gibco; Thermo Fisher Scientific, Inc.) and 1% penicillin/streptomycin (Gibco; Thermo Fisher Scientific, Inc.) in a humidified atmosphere under 5% CO2 at 37°C. The WI-38 and WI-38 VA-13 cell lines were treated with PM10 (9 µg/cm2) for 48 h.

Cell viability assay

A Cell Counting Kit-8 (CCK-8; Dojindo Laboratories, Inc.) was used to conduct the cell viability assays (15). WI38 and WI38 VA-13 cells were seeded in 6-well plates at 4×105 cells/well and incubated for 24 h. Following PM10 treatment for 48 h, CCK-8 solution and RPMI-1640 medium with 10% FBS were added to each well and incubated under 5% CO2 at 37°C for 2 min or 5 min. The absorbance was measured using a microplate reader at 450 nm.

RNA isolation

Total RNA was isolated from WI38 and WI38 VA-13 cell lines using a Qiagen RNeasy Mini kit (74106; Qiagen, Inc.) according to the manufacturer's instructions. The concentration of the isolated RNA was confirmed through a SpectraMax QuickDrop Micro-Volume Spectrophotometer (Molecular Devices, LLC). The 260/280 ratio of the RNA used was >2.1.

RNA-seq and analysis

Using an Illumina TruSeq RNA Sample Preparation kit V2, purification and library construction were conducted with total RNA and Illumina HiSeq 2500 machines (Illumina, Inc.) were used for sequencing with a read length of 2×100 bases. FastQC v.0.11.4 (https://www.bioinformatics.babraham.ac.uk/projects/fastqc/) was used to assess the quality of the paired-end reads. Cutadapt v.1.15 (https://cutadapt.readthedocs.io/en/v1.15/) and Sickle v.1.33 (https://github.com/najoshi/sickle/releases) were used to filter low-quality reads and adaptors. Cufflinks v.2.2.1 (http://cole-trapnell-lab.github.io/cufflinks/) was used to calculate fragments per kilobase of transcripts per million mapped reads values. Cuffdiff (http://cole-trapnell-lab.github.io/cufflinks/) was used to select differentially expressed genes (DEGs; fold change >2). All GO analyses were performed using DAVID v.6.8 (https://david.ncifcrf.gov/) and ClueGO v.2.5.5 in Cytoscape v.3.7.1 (https://cytoscape.org/) (16).

Wound healing assay

WI38 and WI38 VA-13 cells (80% confluence) were seeded in 6-well plates at 4×105 cells/well using MEM and RPMI-1640 medium, respectively, supplemented with 10% FBS and wounded by scratching with sterile plastic 10 µl micropipette tips after 24 h of PM10 treatment (17). Images were taken of the cells at 0 and 24 h after wounding using a CELENATM S Digital Imaging System (Logos Biosystems). Cell migration distance was measured in the images by using ImageJ software version 1.8 (National Institutes of Health).

Flow cytometric cell sorting analysis

After PM10 treatment for 48 h, WI38 and WI38 VA-13 cells were collected and incubated with the Muse Annexin V and Dead Cell Assay kit (cat. no. MCH100105; Luminex Corporation) for 20 min at room temperature in the dark. Following incubation, 5×104 cells were analyzed using a Muse cell analyzer (Merck KGaA). The results were analyzed using Muse 1.5 analysis software (Merck KGaA).

Statistical analysis

The results were expressed as the means ± SDs (error bars) of three independent experiments. An unpaired Student's t-test was performed using GraphPad Prism 5.0 (GraphPad Software, Inc.). P<0.05 was considered to indicate a statistically significant difference.

Results

Research strategy for the biological effects of PM10 based on RNA-seq analysis in lung cell lines

To evaluate the biological effects of PM10 treatment in lung cells, two types of normal lung cell lines (WI-38, fibroblast cells and WI-38 VA-13, epithelial cells) were selected. Following PM10 treatment for 48 h, the total RNA was extracted and performed RNA-seq for a bioinformatic analysis (GO analysis). Cell-specific PM10 effects were evaluated and the biological relationship between the lung and PM predicted (Fig. 1). To assess the effect of PM10 on cell viability, CCK-8 and flow cytometric cell sorting analysis was performed following treatment with PM10 for 48 h. In Fig. 2A, although no significant effects on cell viability were observed as a result of PM10 treatment, slightly decreased cell growth was observed using bright field microscopy (Fig. 2B). Flow cytometric cell sorting analysis with Annexin V showed that the proportion of apoptotic cells in the PM10 treatment group was increased compared with that in the PBS group in both cell lines (Fig. 2C). This suggested that PM10 treatment may affect cell growth via induction of apoptosis. To verify whether PM10 treatment affected cell migration, wound healing analysis was performed following the treatment of two cell lines with PM10. The rate of migration in VA-13 cells was decreased compared with that in the PBS treatment group. However, no difference in the migration rate in the WI-38 cell line was observed (Fig. 2D). Therefore, it was suggested that acute treatment with PM10 could induce cell apoptosis in the two cell lines, but inhibited the migration rate only in epithelial cells (VA-13), not in fibroblasts (WI-38).

Figure 1.

Research strategy for PM10 treatment of WI-38 or WI-38 VA-13 cells. PM, particulate matter; DAVID, Database for Annotation, Visualization and Integrated Discovery; GO, Gene Ontology; DEGs, differentially expressed genes; RNA-seq, RNA sequencing; ClueGO, Clustering Gene Ontology.

Figure 2.

Cellular response to PM10 treatment of WI-38 or WI-38 VA-13 cells. (A) Cell viability assay following PM10 treatment for 48 h. Cell Counting Kit-8 solution was added to the culture medium and the cells were incubated for 5 min at 37°C. Cell growth was measured using a microplate reader (450 nm). The mean ± SD of three independent experiments is shown. The P-values were calculated using Student's t-test. (B) Bright-field images following PM10 treatment. Scale bar, 200 µm. (C) Flow cytometric cell sorting analysis of Annexin V staining was performed following PM10 treatment. The lower right and upper right quadrants indicate early apoptosis and late apoptosis (left), followed by quantification of apoptosis (right). Mean ± SD of three independent experiments is shown. P-values were calculated using Student's t-test. **P<0.01. (D) Wound-healing assay. After 48 h of PM10 treatment, scratch assays of the WI-38 (above) and/or WI-38 VA-13 (below) cell lines were performed. After 24 h, wound closure was measured (right). The mean ± SD of three independent experiments is shown. The P-values were calculated using Student's t-test. ***P<0.001. PM, particulate matter; n.s., non-significant; PBS, phosphate-buffered saline.

PM10 treatment affects the adhesion and extracellular matrix (ECM) of fibroblasts

RNA-seq analysis was used to observe the cell-specific DEGs in WI-38 and WI-38 VA-13 normal lung cell lines. Using 552 WI-38-specific DEGs, GO analysis was performed using the ClueGO plugin in Cytoscape (Fig. 3A). Fig. 3A shows that PM10 treatment was associated with ‘apoptotic process’, ‘signal transduction’, ‘regulation of immune system process’, ‘structure morphogenesis’ and ‘positive regulation of metabolic process’. Additionally, heatmap analysis identified 189 downregulated genes and 363 upregulated genes following treatment with PM10 in WI-38 cell lines (Fig. 3B). The 189 downregulated genes in the GO term analysis were associated with migration-related terms (‘melanocyte migration’ and ‘regulation of epithelial cell migration’), cell growth-related terms (‘regulation of cell growth’ and ‘negative regulation of cell growth’) and adhesion-related terms (‘muscle contraction’, ‘cell-substrate adhesion’ and ‘extracellular matrix organization’). In addition, the 363 upregulated genes were associated with ‘cell cycle arrest’, the ‘extrinsic apoptotic signaling pathway’ and ‘oxidation-reduction processes’ (Fig. 3C). In conclusion, it was suggested that PM10 treatment affected cell growth (‘extrinsic apoptotic signaling pathway’, ‘cell cycle arrest’ and ‘negative regulation of cell growth’), cell adhesion and ECM organization in fibroblasts.

Figure 3.

PM10 downregulates cell growth and adhesion terms in WI-38 cells. (A) Venn diagram of DEGs (above) and GO analysis (biological processes) of the DEGs following PM10 treatment in WI-38 grouped only by Clustering GO (below). (B) Heatmap of 552 WI-38-specific genes. (C) Database for Annotation, Visualization and Integrated Discovery-based GO analysis of RNA-sequencing results for 552 up- and downregulated genes. The enriched terms are shown. PM, particulate matter; DEGs, differentially expressed genes; GO, Gene Ontology.

PM10 induces ER stress in WI-38 VA-13 epithelial cells

Following PM10 treatment, 477 WI-38 VA-13-specific DEGs were identified using RNA-seq. For the WI-38 VA-13-specific DEGs, a GO analysis was performed using the ClueGO plugin in Cytoscape and associations with terms related to ‘immune system process’, ‘cellular response to chemical stimulus’, ‘regulation of metabolic process’ and ‘biosynthetic process’ were found (Fig. 4A). To analyze the 477 DEGs in greater detail, a heatmap analysis (246 downregulated genes and 231 upregulated genes) was performed (Fig. 4B). The 246 downregulated genes were clearly associated with ‘negative regulation of apoptotic process’, ‘G2/M transition of mitotic cell cycle’, ‘cell-cell adhesion’, ‘cholesterol biosynthetic process via lathosterol’ and ‘cholesterol biosynthetic process via desmosterol’. In addition, the 231 upregulated genes were related to ER stress terms, including ‘positive regulation of endoplasmic reticulum stress’, ‘PERK-mediated unfolded protein response’ and ‘negative regulation of endopeptidase activity’ (Fig. 4C).

Figure 4.

PM10 upregulates endoplasmic reticulum stress and apoptosis terms in WI-38 VA-13 cells. (A) Venn diagram of DEGs (above) and GO analysis (biological processes) of the DEGs following PM10 treatment in WI-38 VA-13 grouped only by Clustering GO (below). (B) Heatmap of 477 WI-38-specific genes. (C) Database for Annotation, Visualization and Integrated Discovery-based GO analysis of RNA-sequencing results for the 477 up- and downregulated genes. The enriched terms are shown. PM, particulate matter; DEGs, differentially expressed genes; GO, Gene Ontology.

PM10 treatment is related to apoptotic processes in fibroblast and epithelial cell lines. In the analysis of DEGs, 107 genes were expressed in both the WI38 and WI-38 VA-13 cell lines following PM10 treatment. The GO analysis showed that the terms related to ‘regulation of primary metabolic process’ and ‘cellular response’ were enriched in genes affected by PM10 treatment (Fig. 5A). Additionally, the heatmap and GO analysis using DAVID indicated that DEGS in the two cell lines were associated with apoptosis processes, protein folding and signaling pathways (‘p38 MAPK cascade’ and ‘negative regulation of protein kinase B signaling’) following PM10 treatment (Fig. 5B and C). Thus, at the transcriptome level, PM10 treatment was associated with negative cell growth-related GO terms.

Figure 5.

Overlapping DEGs following PM10 treatment in WI-38 and WI-38 VA-13 cells. (A) Venn diagram of DEGs (above) and GO analysis (biological processes) of the overlapping DEGs following PM10 treatment in WI-38 and WI-38 VA-13 grouped by Clustering GO (below). (B) Heatmap of 107 WI-38-specific genes. (C) Database for Annotation, Visualization and Integrated Discovery-based GO analysis of RNA-sequencing results for the 107 up- and downregulated genes. The enriched terms are shown. (D) Schematic summary of PM-induced biological responses. DEGs, differentially expressed genes; GO, Gene Ontology; PM, particulate matter; ER, endoplasmic reticulum.

Discussion

GO analysis (DAVID and ClueGO) is a useful method for evaluating the total biological response of normal lung cell lines following PM10 treatment using cell-specific DEGs (18). The present study presented the cell-specific responses to PM10 observed in the cell lines WI-38 (lung fibroblast cells) and WI-38 VA-13 (lung epithelial cells) via transcriptome analysis using RNA-seq results. To select the PM10 concentration for the assessment of cellular response in normal lung cell lines, a high concentration of PM10 was selected in the present study. Chen et al (19) demonstrate that a concentration of 10 µg/m3 PM10 is associated with lung cancer mortality (3.4~6% increase) in a cohort of 39,054 participants. From a cohort study conducted for 12 years, Quezada-Maldonado et al (20) report that a high concentration (10 µg/cm3) of PM10 elicits an acute cellular response in lung tumors, changing the expression of 45 miRNAs for 72 h. At the in vitro level, cell culture is difficult to maintain in the long term following PM10 treatment. Thus, the present study decided on short-term cell culture following treatment with a high concentration of PM10 (9 µg/cm3) for 48 h to determine the cellular effects of PM10 treatment. Hence, it demonstrated that continuous acute stimulation by PM10 had negative effects on cells and the loss of homeostasis in the cells may induce several types of disease in humans. However, future animal studies are needed to examine the long-term effects of PM10.

Lung epithelial cells serve an important role in maintaining lung homeostasis and host defense mechanisms. In wound sites caused by toxins, PM and pathogens, several epithelial cell types spread and migrate as part of repair processes in the lung (21,22). In wound healing analysis following PM10 treatment, it was clearly observed that PM10 treatment suppressed wound closure in epithelial cells (VA-13), implying that PM10 exposure may inhibit the wound healing process in the lung defense mechanisms. Additionally, in flow cytometric cell sorting analysis, the induction of apoptosis by PM10 treatment was associated with GO term results (‘negative regulation of cell proliferation’ and ‘apoptosis’). Thus, PM10 treatment in epithelial cells may be a potential risk factor for several types of lung disease.

Lung fibroblasts produce ECM components, including elastin, type III collagen and proteoglycan, for lung structure and cell adhesion. The ECM is an important factor for physical support and normal organ function (23,24). Although the present study could not detect significant differences in cell growth and wound healing analysis following PM10 treatment, transcriptome analysis clearly revealed the enrichment of GO terms (‘cell adhesion’, ‘cell growth’ and ‘extracellular matrix organization’) suggesting that the primary functions of fibroblasts in the lung were slightly affected by exposure to PM10 and it was considered that continuous PM10 exposure may cause functional defects under normal conditions in lung fibroblasts.

Finally, in the DEGs of both cell types, PM10 induced changes related to apoptotic processes and metabolic signaling processes. Thus, the present study suggested that although brief exposure to PM10 was slightly reflected in phenotypic changes in cell processes including cell growth, various processes represented by functional GO terms (apoptotic GO terms and cell proliferation GO terms) were fully induced by PM10 treatment. In brief, longer exposure to PM10 may affect cell conditions and smaller particles (PM2.5 or PM1.0) could have stronger effects on lung epithelial or fibroblast cells.

In summary, RNA-seq analysis was performed on lung epithelial cells and fibroblast cells to identify cell-specific responses to PM10 treatment. GO analysis of DEGs showed that PM10 treatment was associated with terms related to cell apoptosis, immune system processes, cell cycle arrest and ER stress. Thus, the present study suggested that exposure to PM may affect cell conditions and long-term exposure to PM is likely to result in various disease processes (Fig. 5D).

Acknowledgements

Not applicable.

Funding

The present study was supported by grants from the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (grant nos. 2018M3A9H3023077/2021M3A9H3016046, 2019R1I1A2A01060140 and 2020R1A2B5 B01002028) and by the KRIBB and KIST Research Initiative Program.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.

Authors' contributions

Conception and design was conducted by DSK, MSL, YJP and HSC. TYR, JL, KK and SJL developed the methodology. Analysis and interpretation of data was conducted by KP, MYS and HSC. Manuscript writing and reviewing was performed by SJL, DSK, MSL and YJP. Study supervision was by DSK and HSC. All authors have read and approved the final manuscript. HSC and DSK confirm the authenticity of all the raw data.

Ethics approval and consent to participate

Not applicable.

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Glossary

Abbreviations

Abbreviations:

PM10

particulate matter10

DAVID

Database for Annotation, Visualization and Integrated Discovery

ClueGO

Clustering Gene Ontology

DEGs

differentially expressed genes

ECM

extracellular matrix

DNMT

DNA methyltransferase

FBS

fetal bovine serum

PBS

phosphate-buffered saline

CCK-8

Cell Counting Kit-8

ER stress

endoplasmic reticulum stress

References

1 

Kyung SY and Jeong SH: Particulate-matter related respiratory diseases. Tuberc Respir Dis (Seoul). 83:116–121. 2020. View Article : Google Scholar : PubMed/NCBI

2 

Li T, Hu R, Chen Z, Li Q, Huang S, Zhu Z and Zhou LF: Fine particulate matter (PM2.5): The culprit for chronic lung diseases in China. Chronic Dis Transl Med. 4:176–186. 2018.PubMed/NCBI

3 

Zou Y, Wu Y, Wang Y, Li Y and Jin C: Physicochemical properties, in vitro cytotoxic and genotoxic effects of PM1.0 and PM2.5 from Shanghai, China. Environ Sci Pollut Res Int. 24:19508–19516. 2017. View Article : Google Scholar : PubMed/NCBI

4 

Huang SL, Hsu MK and Chan CC: Effects of submicrometer particle compositions on cytokine production and lipid peroxidation of human bronchial epithelial cells. Environ Health Perspect. 111:478–482. 2003. View Article : Google Scholar : PubMed/NCBI

5 

Mu Q, Jiang G, Chen L, Zhou H, Fourches D, Tropsha A and Yan B: Chemical basis of interactions between engineered nanoparticles and biological systems. Chem Rev. 114:7740–7781. 2014. View Article : Google Scholar : PubMed/NCBI

6 

Huang F, Wang P, Pan X, Wang Y and Ren S: Effects of short-term exposure to particulate matters on heart rate variability: A systematic review and meta-analysis based on controlled animal studies. Environ Pollut. 256:1133062020. View Article : Google Scholar : PubMed/NCBI

7 

Pfeffer PE, Lu H, Mann EH, Chen YH, Ho TR, Cousins DJ, Corrigan C, Kelly FJ, Mudway IS and Hawrylowicz CM: Effects of vitamin D on inflammatory and oxidative stress responses of human bronchial epithelial cells exposed to particulate matter. PLoS One. 13:e02000402018. View Article : Google Scholar : PubMed/NCBI

8 

Watterson TL, Hamilton B, Martin RS and Coulombe RA Jr: Urban particulate matter activates Akt in human lung cells. Arch Toxicol. 86:121–135. 2012. View Article : Google Scholar : PubMed/NCBI

9 

Hesselbach K, Kim GJ, Flemming S, Häupl T, Bonin M, Dornhof R, Günther S, Merfort I and Humar M: Disease relevant modifications of the methylome and transcriptome by particulate matter (PM2.5) from biomass combustion. Epigenetics. 12:779–792. 2017. View Article : Google Scholar : PubMed/NCBI

10 

Zhang N, Liu K, Wang K, Zhou C, Wang H, Che S, Liu Z and Yang H: Dust induces lung fibrosis through dysregulated DNA methylation. Environ Toxicol. 34:728–741. 2019. View Article : Google Scholar : PubMed/NCBI

11 

Wei T and Tang M: Biological effects of airborne fine particulate matter (PM2.5) exposure on pulmonary immune system. Environ Toxicol Pharmacol. 60:195–201. 2018. View Article : Google Scholar : PubMed/NCBI

12 

Travaglini KJ, Nabhan AN, Penland L, Sinha R, Gillich A, Sit RV, Chang S, Conley SD, Mori Y, Seita J, et al: A molecular cell atlas of the human lung from single-cell RNA sequencing. Nature. 587:619–625. 2020. View Article : Google Scholar : PubMed/NCBI

13 

Ito Y, Correll K, Schiel JA, Finigan JH, Prekeris R and Mason RJ: Lung fibroblasts accelerate wound closure in human alveolar epithelial cells through hepatocyte growth factor/c-Met signaling. Am J Physiol Lung Cell Mol Physiol. 307:L94–L105. 2014. View Article : Google Scholar : PubMed/NCBI

14 

Hsia CC, Hyde DM and Weibel ER: Lung structure and the intrinsic challenges of gas exchange. Compr Physiol. 6:827–895. 2016. View Article : Google Scholar : PubMed/NCBI

15 

Lee J, Kim K, Ryu TY, Jung CR, Lee MS, Lim JH, Park K, Kim DS, Son MY, et al: EHMT1 knockdown induces apoptosis and cell cycle arrest in lung cancer cells by increasing CDKN1A expression. Mol Oncol. 15:2989–3002. 2021. View Article : Google Scholar : PubMed/NCBI

16 

Lee H, Son YS, Lee MO, Ryu JW, Park K, Kwon O, Jung KB, Kim K, Ryu TY, Baek A, et al: Low-dose interleukin-2 alleviates dextran sodium sulfate-induced colitis in mice by recovering intestinal integrity and inhibiting AKT-dependent pathways. Theranostics. 10:5048–5063. 2020. View Article : Google Scholar : PubMed/NCBI

17 

Cappiello F, Casciaro B and Mangoni ML: A novel in vitro wound healing assay to evaluate cell migration. J Vis Exp. 568252018.PubMed/NCBI

18 

Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al: Gene ontology: Tool for the unification of biology. The gene ontology consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI

19 

Chen X, Zhang LW, Huang JJ, Song FJ, Zhang LP, Qian ZM, Trevathan E, Mao HJ, Han B, Vaughn M, et al: Long-term exposure to urban air pollution and lung cancer mortality: A 12-year cohort study in Northern China. Sci Total Environ. 571:855–861. 2016. View Article : Google Scholar : PubMed/NCBI

20 

Quezada-Maldonado EM, Sanchez-Perez Y, Chirino YI, Vaca-Paniagua F and Garcia-Cuellar CM: miRNAs deregulation in lung cells exposed to airborne particulate matter (PM10) is associated with pathways deregulated in lung tumors. Environ Pollut. 241:351–358. 2018. View Article : Google Scholar : PubMed/NCBI

21 

Croasdell Lucchini A, Gachanja NN, Rossi AG, Dorward DA and Lucas CD: Epithelial cells and inflammation in pulmonary wound repair. Cells. 10:3392021. View Article : Google Scholar : PubMed/NCBI

22 

Farooqui R and Fenteany G: Multiple rows of cells behind an epithelial wound edge extend cryptic lamellipodia to collectively drive cell-sheet movement. J Cell Sci. 118:51–63. 2005. View Article : Google Scholar : PubMed/NCBI

23 

Pardo A and Selman M: Lung fibroblasts, aging, and idiopathic pulmonary fibrosis. Ann Am Thorac Soc. 13 (Suppl 5):S417–S421. 2016. View Article : Google Scholar : PubMed/NCBI

24 

White ES: Lung extracellular matrix and fibroblast function. Ann Am Thorac Soc. 12 (Suppl 1):S30–S33. 2015. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Park K, Kim K, Ryu TY, Lee J, Lee M, Son M, Lee S, Park Y, Cho H, Kim D, Kim D, et al: Cellular response of lung fibroblasts and epithelial cells to particulate matter<sub>10</sub> treatment examined via comparative transcriptome analysis. Mol Med Rep 25: 82, 2022.
APA
Park, K., Kim, K., Ryu, T.Y., Lee, J., Lee, M., Son, M. ... Kim, D. (2022). Cellular response of lung fibroblasts and epithelial cells to particulate matter<sub>10</sub> treatment examined via comparative transcriptome analysis. Molecular Medicine Reports, 25, 82. https://doi.org/10.3892/mmr.2022.12598
MLA
Park, K., Kim, K., Ryu, T. Y., Lee, J., Lee, M., Son, M., Lee, S., Park, Y., Cho, H., Kim, D."Cellular response of lung fibroblasts and epithelial cells to particulate matter<sub>10</sub> treatment examined via comparative transcriptome analysis". Molecular Medicine Reports 25.3 (2022): 82.
Chicago
Park, K., Kim, K., Ryu, T. Y., Lee, J., Lee, M., Son, M., Lee, S., Park, Y., Cho, H., Kim, D."Cellular response of lung fibroblasts and epithelial cells to particulate matter<sub>10</sub> treatment examined via comparative transcriptome analysis". Molecular Medicine Reports 25, no. 3 (2022): 82. https://doi.org/10.3892/mmr.2022.12598
Copy and paste a formatted citation
x
Spandidos Publications style
Park K, Kim K, Ryu TY, Lee J, Lee M, Son M, Lee S, Park Y, Cho H, Kim D, Kim D, et al: Cellular response of lung fibroblasts and epithelial cells to particulate matter<sub>10</sub> treatment examined via comparative transcriptome analysis. Mol Med Rep 25: 82, 2022.
APA
Park, K., Kim, K., Ryu, T.Y., Lee, J., Lee, M., Son, M. ... Kim, D. (2022). Cellular response of lung fibroblasts and epithelial cells to particulate matter<sub>10</sub> treatment examined via comparative transcriptome analysis. Molecular Medicine Reports, 25, 82. https://doi.org/10.3892/mmr.2022.12598
MLA
Park, K., Kim, K., Ryu, T. Y., Lee, J., Lee, M., Son, M., Lee, S., Park, Y., Cho, H., Kim, D."Cellular response of lung fibroblasts and epithelial cells to particulate matter<sub>10</sub> treatment examined via comparative transcriptome analysis". Molecular Medicine Reports 25.3 (2022): 82.
Chicago
Park, K., Kim, K., Ryu, T. Y., Lee, J., Lee, M., Son, M., Lee, S., Park, Y., Cho, H., Kim, D."Cellular response of lung fibroblasts and epithelial cells to particulate matter<sub>10</sub> treatment examined via comparative transcriptome analysis". Molecular Medicine Reports 25, no. 3 (2022): 82. https://doi.org/10.3892/mmr.2022.12598
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team